Levitte, S.; Yarani, R.; Ganguly, A.; Martin, L.; Gubatan, J.; Nadel, H.R.; Franc, B.; Gugig, R.; Syed, A.; Goyal, A.;
et al. Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program. J. Clin. Med. 2023, 12, 2386.
https://doi.org/10.3390/jcm12062386
AMA Style
Levitte S, Yarani R, Ganguly A, Martin L, Gubatan J, Nadel HR, Franc B, Gugig R, Syed A, Goyal A,
et al. Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program. Journal of Clinical Medicine. 2023; 12(6):2386.
https://doi.org/10.3390/jcm12062386
Chicago/Turabian Style
Levitte, Steven, Reza Yarani, Abantika Ganguly, Lynne Martin, John Gubatan, Helen R. Nadel, Benjamin Franc, Roberto Gugig, Ali Syed, Alka Goyal,
and et al. 2023. "Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program" Journal of Clinical Medicine 12, no. 6: 2386.
https://doi.org/10.3390/jcm12062386
APA Style
Levitte, S., Yarani, R., Ganguly, A., Martin, L., Gubatan, J., Nadel, H. R., Franc, B., Gugig, R., Syed, A., Goyal, A., Park, K. T., & Thakor, A. S.
(2023). Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program. Journal of Clinical Medicine, 12(6), 2386.
https://doi.org/10.3390/jcm12062386
